Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoral segmental defect model

Journal of Korean Medical Science

Volumn 26, Issue 4, 2011, Pages 482-491

  Choi, Hyung Jun ^a,b   Kim, Jong Min ^b   Kwon, Euna ^b   Che, Jeong Hwan ^b   Lee, Jae Il ^b   Cho, Seong Ryul ^c   Kang, Sung Keun ^c   Ra, Jeong Chan ^c   Kang, Byeong Cheol ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c RNL BIO Co Ltd   (South Korea)

Author keywords

Bone Defect Model; Efficacy; HA TCP Scaffold; Human Adipose Tissue Derived Mesenchymal Stem Cells; Nude Rats; Safety

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE; HYDROXYAPATITE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BONE DISEASE; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAPHYSIS; DISEASE MODEL; FEMUR; HUMAN; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NUDE RAT; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; RAT; TISSUE ENGINEERING; ULTRASTRUCTURE; XENOGRAFT;

ADIPOSE TISSUE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE DISEASES; BONE REGENERATION; CALCIUM PHOSPHATES; DIAPHYSES; DISEASE MODELS, ANIMAL; DURAPATITE; FEMUR; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, NUDE; TISSUE ENGINEERING; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, HETEROLOGOUS;

EID: 79953752590     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.4.482     Document Type: Article

References (26)

1. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M, Ota H, Miyamoto S, Nozaki K, Takaoka K. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am 2001; 83-A Suppl 1: S92-8.
2. Ikeuchi M, Dohi Y, Horiuchi K, Ohgushi H, Noshi T, Yoshikawa T, Yamamoto K, Sugimura M. Recombinant human bone morphogenetic protein-2 promotes osteogenesis within atelopeptide type I collagen solution by combination with rat cultured marrow cells. J Biomed Mater Res 2002; 60: 61-9.
3. Boo JS, Yamada Y, Okazaki Y, Hibino Y, Okada K, Hata K, Yoshikawa T, Sugiura Y, Ueda M. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg 2002; 13: 231-9.
4. Dong J, Uemura T, Shirasaki Y, Tateishi T. Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow-derived osteoprogenitor cells. Biomaterials 2002; 23: 4493-502.
5. Tancred DC, Carr AJ, McCormack BA. Development of a new synthetic bone graft. J Mater Sci Mater Med 1998; 9: 819-23.
6. Walsh WR, Vizesi F, Michael D, Auld J, Langdown A, Oliver R, Yu Y, Irie H, Bruce W. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 2008; 29: 266-71.
7. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-9.
8. Zhou YF, Bosch-Marce M, Okuyama H, Krishnamachary B, Kimura H, Zhang L, Huso DL, Semenza GL. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 2006; 66: 10849-54.
9. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, Stamp G, Bonnet D, Janes SM. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007; 25: 1586-94.
10. Tasso R, Augello A, Carida M, Postiglione F, Tibiletti MG, Bernasconi B, Astigiano S, Fais F, Truini M, Cancedda R, Pennesi G. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. Carcinogenesis 2009; 30: 150-7.
11. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998; 16: 155-62.
12. Muraglia A, Corsi A, Riminucci M, Mastrogiacomo M, Cancedda R, Bianco P, Quarto R. Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci 2003; 116: 2949-55.
13. Kadiyala S, Jaiswal N, Bruder S. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng 1997; 3: 173-85.
14. Wan C, He Q, Li G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 2006; 24: 610-8.
15. Xia Z, Ye H, Choong C, Ferguson DJ, Platt N, Cui Z, Triffitt JT. Macrophagic response to human mesenchymal stem cell and poly (epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice. J Biomed Mater Res A 2004; 71: 538-48.
16. Jager M, Degistirici O, Knipper A, Fischer J, Sager M, Krauspe R. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 2007; 22: 1224-33.
17. Lawrenz B, Schiller H, Willbold E, Ruediger M, Muhs A, Esser S. Highly sensitive biosafety model for stem-cell-derived grafts. Cytotherapy 2004; 6: 212-22.
18. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-8.
19. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-6.
20. Kim WS, Kim HK. Tissue engineered vascularized bone formation using in vivo implanted osteoblast-polyglycolic acid scaffold. J Korean Med Sci 2005; 20: 479-82.
21. Daculsi G, LeGeros RZ, Nery E, Lynch K, Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mater Res 1989; 23: 883-94.
22. Nery EB, Lynch KL, Hirthe WM, Mueller KH. Bioceramic implants in surgically produced infrabony defects. J Periodontol 1975; 46: 328-47.
23. Quintavalla J, Uziel-Fusi S, Yin J, Boehnlein E, Pastor G, Blancuzzi V, Singh HN, Kraus KH, O'Byrne E, Pellas TC. Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials 2002; 23: 109-19.
24. Tatebe M, Nakamura R, Kagami H, Okada K, Ueda M. Differentiation of transplanted mesenchymal stem cells in a large osteochondral defect in rabbit. Cytotherapy 2005; 7: 520-30.
25. Shao X, Goh JC, Hutmacher DW, Lee EH, Zigang G. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. Tissue Eng 2006; 12: 1539-51.
26. Yamazoe K, Mishima H, Torigoe K, Iijima H, Watanabe K, Sakai H, Kudo T. Effects of atelocollagen gel containing bone marrow-derived stromal cells on repair of osteochondral defect in a dog. J Vet Med Sci 2007; 69: 835-9.